| Dear Fellow Investor, In April 2021, NVIDIA partnered with a tiny biotech to help power its AI-drug discovery platform. Six months later, its AI discovered a new treatment for multiple myeloma. Six months after that, Eli Lilly signed a $425 million deal to have them develop new drugs. Six months after that, Bristol Myers Squibb signed a $2.7 billion deal to have its AI-platform develop new drugs.
That's why Bill Gates, BlackRock and Morgan Stanley own 16 million shares of this "little-known" company.
Get the name of this small-cap here >>>
"The Buck Stops Here," | 
